REQUEST A DEMO
Total
USD $0.00
Search more companies

Csc Pharmaceuticals Private Limited (India)

Main Activities: Wholesale Electronic Markets and Agents and Brokers
Full name: Csc Pharmaceuticals Private Limited Profile Updated: May 28, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Csc Pharmaceuticals Private Limited is a company based in India, with its head office in Panchkula. The enterprise operates in the Wholesale Electronic Markets and Agents and Brokers industry. It was established on March 24, 2021. Csc Pharmaceuticals Private Limited currently employs 5 (2025) people. The latest financial highlights indicate a net sales revenue increase of 0.37% in 2024. Its’ total assets recorded a negative growth of 1.99%. The net profit margin of Csc Pharmaceuticals Private Limited increased by 0.22% in 2024.

Legal Address
Sco-10, Sector-5, Near Wah Dilli
Panchkula; Haryana; Postal Code: 134109

Contact Details: Purchase the Csc Pharmaceuticals Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Csc Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Csc Pharmaceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the Csc Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
March 24, 2021
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Csc Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
0.37%
Total Operating Revenue
0.36%
Operating Profit
12.08%
EBITDA
21.41%
Net Profit/Loss for the Period
8.13%
Total Assets
-1.99%
Total Equity
54.03%
Operating Profit Margin
0.63%
Net Profit Margin
0.22%
Return on Equity (ROE)
-14.89%
Debt / Equity
36.16%
Quick Ratio
0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?